Effect of dulaglutide on cognitive impairment in type 2 diabetes: an exploratory analysis of the REWIND trial-Reference-Cited by-同舟云学术

Effect of dulaglutide on cognitive impairment in type 2 diabetes: an exploratory analysis of the REWIND trial

Published:2020-07 Issue:7 Volume:19 Page:582-590
ISSN:1474-4422
Container-title:The Lancet Neurology
language:en
Short-container-title:The Lancet Neurology

Author:

Cukierman-Yaffe Tali,Gerstein Hertzel C,Colhoun Helen M,Diaz Rafael,García-Pérez Luis-Emilio,Lakshmanan Mark,Bethel Angelyn,Xavier Denis,Probstfield Jeffrey,Riddle Matthew C,Rydén Lars,Atisso Charles Messan,Hall Stephanie,Rao-Melacini Purnima,Basile Jan,Cushman William C,Franek Edward,Keltai Matyas,Lanas Fernando,Leiter Lawrence A,Lopez-Jaramillo Patricio,Pirags Valdis,Pogosova Nana,Raubenheimer Peter J,Shaw Jonathan E,Sheu Wayne H-H,Temelkova-Kurktschiev Theodora

Publisher

Elsevier BV

Subject

Neurology (clinical)

Reference30 articles.

1. Diabetes mellitus and risk of dementia: a meta-analysis of prospective observational studies;Gudala;J Diabetes Investig,2013

2. Cognitive decline and dementia in diabetes-systematic overview of prospective observational studies;Cukierman;Diabetologia,2005

3. Risk of hypoglycemia in older veterans with dementia and cognitive impairment: implications for practice and policy;Feil;J Am Geriatr Soc,2011

4. Vascular cognitive impairment;O'Brien;Lancet Neurol,2003

5. Cognitive impairment and cardiovascular disease: a comparison of risk factors, disability, quality of life, and access to health care;Adams;Public Health Rep,2020

Cited by 155 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. The GLP-1 medicines semaglutide and tirzepatide do not alter disease-related pathology, behaviour or cognitive function in 5XFAD and APP/PS1 mice;Molecular Metabolism;2024-11

2. Sodium–glucose cotransporter 2 inhibition through henagliflozin ameliorates cognitive impairment in patients with type 2 diabetes;Journal of Diabetes Investigation;2024-09-10

3. Advances and counterpoints in type 2 diabetes. What is ready for translation into real-world practice, ahead of the guidelines;BMC Medicine;2024-09-04

4. Sodium–Glucose Cotransporter-2 Inhibitors, Dulaglutide, and Risk for Dementia;Annals of Internal Medicine;2024-08-27

5. IL-6 LEVELS AND COGNITIVE COMPLICATIONS IN PATIENTS WITH TYPE 2 DIABETES MELLITUS: A CROSS SECTIONAL STUDY;Ankara Universitesi Eczacilik Fakultesi Dergisi;2024-08-06